发明申请
US20120021925A1 DIAGNOSTIC ASSAYS FOR PROSTATE CANCER USING PSP94 AND PSA BIOMARKERS
审中-公开
使用PSP94和PSA生物标志物进行前列腺癌的诊断测定
- 专利标题： DIAGNOSTIC ASSAYS FOR PROSTATE CANCER USING PSP94 AND PSA BIOMARKERS
- 专利标题（中）： 使用PSP94和PSA生物标志物进行前列腺癌的诊断测定
-
申请号： US13144662申请日： 2010-01-19
-
公开(公告)号： US20120021925A1公开(公告)日： 2012-01-26
- 发明人: Katrin Atnikov , Douglas Barker , Yilan Zhang , Stephen Frost
- 申请人： Katrin Atnikov , Douglas Barker , Yilan Zhang , Stephen Frost
- 申请人地址： CA Winnipeg
- 专利权人： MIRACULINS, INC.
- 当前专利权人： MIRACULINS, INC.
- 当前专利权人地址： CA Winnipeg
- 国际申请： PCT/CA10/00078 WO 20100119
- 主分类号： C40B30/00
- IPC分类号： C40B30/00 ; H01J49/40 ; C12Q1/37 ; H01J49/26 ; G01N33/577 ; G01N21/64
摘要：
The application refers to a method for diagnosing prostate cancer through the measurement of the combination of PSP94 (β-microseminoprotein) and F/T PSA biomarkers, the method using urine samples to measure PSP94 and serum samples to analyse F/T PSA. In one embodiment, the PSP94 is standardized to creatinine. Also based on the measurement of PSP94 and F/T PSA are provided methods and kits for (a) diagnosing aggressive prostate cancer; (b) differential diagnosis; and (c) diagnosing the progression of prostate cancer.
信息查询
